FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HUNTER CHRISTOPHER H. 		2. Issuer Name and Ticker or Trading Symbol

HUMANA INC [ HUM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP and Chief Strategy Officer
(Last)          (First)          (Middle)

HUMANA INC., 500 WEST MAIN STREET 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/18/2017
(Street)

LOUISVILLE, KY 40202
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Humana Common   2/18/2017     M    7889   (7) A $0   16855   D  
 
Humana Common   2/18/2017     F    3869   D $205.325   12986   D  
 
Humana Common   2/22/2017     S    4020   D $205.204   (8) 8966   D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options   (1) $102.155                      (1) 2/18/2021   Humana Common   11175     11175   D  
 
Options   (2) $164.645                      (2) 2/24/2022   Humana Common   14913     14913   D  
 
Options   (3) $167.805                      (3) 2/18/2023   Humana Common   14764     14764   D  
 
Restricted Stock Units   (4)   (4) 2/18/2017     M         2447      (5)   (5) Humana Common   2447   $0   0   D  
 
Restricted Stock Units   (4)   (4)                    (6)   (6) Humana Common   2186     2186   D  
 

Explanation of Responses:
( 1)  Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17.
( 2)  Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to Reporting Person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.
( 3)  Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.
( 4)  Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.
( 5)  Restricted stock units granted to Reporting Person on 02/18/14, 100% of the award is vesting on 02/18/17.
( 6)  Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.
( 7)  Includes both time based (2,447) and performance based (5,442) restricted stock units that vested on 2/18/17.
( 8)  Shares sold at a prices ranging from $205.1975 to $205.2042.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HUNTER CHRISTOPHER H.
HUMANA INC.
500 WEST MAIN STREET
LOUISVILLE, KY 40202

SVP and Chief Strategy Officer

Signatures
Christopher H. Hunter 2/22/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Humana (NYSE:HUM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Humana Charts.
Humana (NYSE:HUM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Humana Charts.